glp-1 cancer reduction Receptor Agonists: Benefits and Risks in Colorectal glp 1 reduce cancer risk

Regarding the participants with MCI or AD, defined based on a clinical dementia rating (CDR) global score of 0.5 or 1, although the 18-month treatment with exenatide was safe and well-tolerated, it did not significantly affect clinical and cognitive measures, nor did it affect MRI cortical thickness and volume or most biomarkers in the cerebrospinal fluid (CSF), plasma, and plasma neuronal extracellular vesicles (EVs)

Gradual Dose Adjustments Digestive side effects are often more noticeable when starting treatment or moving to a higher dose

They work by mimicking the action of GLP-1, a hormone that regulates appetite and promotes weight loss

Animal studies have shown that GLP-1RAs activate fat cell browning and may regulate BAT through the central nervous system